/

Batteries & E-Mobility

/

Vaxcyte

Vaxcyte

Vaxcyte

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

San Carlos, California

·

Since 2013

Vaxcyte is a clinical-stage vaccine development company founded in 2013 and headquartered in San Carlos, California, with 500–1,000 employees. The company engineers broad-spectrum conjugate and novel protein vaccines targeting bacterial infectious diseases including pneumococcal disease, Group A Strep, and Shigella. It serves medical, military-defense, and industrial sectors using its proprietary cell-free protein synthesis platform called XpressCF.

Vaxcyte

Verified Nov 2026

AT A GLANCE

Founded

2013

Headquarters

United States flag

San Carlos, California

Employees

500-1,000

Ownership

Vaxcyte at a glance

Employees

500-1,000

Founded

2013

Headquarters

San Carlos, California

Industries

Automotive

Electric Vehicles

Medical

Military & Defense

Industrial Equipment

Overview

Vaxcyte is a clinical-stage vaccine development company founded in 2013 and headquartered in San Carlos, California, with 500–1,000 employees. The company engineers broad-spectrum conjugate and novel protein vaccines targeting bacterial infectious diseases including pneumococcal disease, Group A Strep, and Shigella. It serves medical, military-defense, and industrial sectors using its proprietary cell-free protein synthesis platform called XpressCF.

At a glance

Attribute

Detail

Founded

2013

Headquarters

San Carlos, California

Employees

500-1,000

Primary capability

Batteries & E-Mobility

What Vaxcyte makes

The company operates a proprietary XpressCF cell-free protein synthesis platform that enables efficient creation of complex protein antigens and optimized protein carriers for vaccine development.

Latest developments

Facilities

Vaxcyte is headquartered in San Carlos, California. Public sources also reference these locations:

Company details

Vaxcyte has contracted with Lonza to expand manufacturing capacity in Visp, Switzerland for its pneumococcal conjugate vaccine candidate VAX-31. Vaxcyte was founded in 2013, has an estimated 500-1,000 employees, and is headquartered in San Carlos, California.

Frequently asked questions

What does Vaxcyte make?

Vaxcyte is a clinical-stage vaccine development company founded in 2013 and headquartered in San Carlos, California, with 500–1,000 employees. The company engineers broad-spectrum conjugate and novel protein vaccines targeting bacterial infectious diseases including pneumococcal disease, Group A Strep, and Shigella. It serves medical, military-defense, and industrial sectors using its proprietary cell-free protein synthesis platform called XpressCF.

Where is Vaxcyte headquartered?

Vaxcyte is headquartered in San Carlos, California (825 Industrial Rd, San Carlos, California, 94070-3312).

When was Vaxcyte founded?

Vaxcyte was founded in 2013.

How big is Vaxcyte?

Vaxcyte has an estimated 500-1,000 employees.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

San Carlos, California (HQ)Headquarters · United States
San Carlos, California (HQ)825 Industrial Rd, San Carlos, California, 94070-3312, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.